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Abstract 
Objectives: 1) Conduct team building activities for provider-community pharmacist teams in small communities and 2) Determine the 
impact of the team approach on practitioner-reported consequences and 3) Identify obstacles to the team approach and ways to 
overcome them. 
Methods: Eleven provider-pharmacist teams were recruited in rural/micropolitan communities in Iowa. The teams participated in 
team building sessions facilitated by the project leaders, to discuss the team approach. Decisions included patient identification, 
practitioner roles, and communications. Most pharmacists conducted blood pressure (BP) checks in the pharmacy and assessed the 
anti-hypertensive medications. If the BP was not at goal, the pharmacist worked with the patient and provider to make 
improvements. Teams followed their strategies for 3-5 months. Data were collected from pharmacy logs and on-line surveys of team 
members before and after the team period. 
Results: Using a multi-case approach, 4 cases were classified as Worked-Well, 5 as Limited-Success, and 2 as No-Team-Care. The 
Worked-Well teams provided an average of 26.5 BP visits per team, while the Limited-Success teams averaged 6.8 BP visits. The 
Worked-Well teams established and used a system to support the team approach. The Limited-Success teams either didn’t fully 
establish their team system, or used it sparingly. The No-Team-Care cases did not provide any team care. 
Conclusions: Factors supporting success were: positive provider-pharmacist relations, established team system, commitment to team 
care, and patient willingness to participate. While this program had some success, potential improvements were identified: more 
follow-up after the team building session, additional patient materials, and guidance for practice changes.  
 
 
Introduction 
According to the Centers for Disease Control and Prevention, 
1 in 3 Americans (67 million) have high BP. In 2009, 
hypertension was the main or underlying cause of 348,000 
deaths and medical expenses totaling $47.5 billion annually in 
the U.S. [1]. Controlling BP reduces the risk for myocardial 
infarction, heart failure, stroke, and other vascular health 
problems. In 2009-2010, 49.1% of whites while, only 31.6% of 
Hispanics and 43.0% of blacks with hypertension had their BP 
under control [2].  
 
Previous studies show BP can be improved with physician-
pharmacist collaboration [3-6]. In a review of 63 clinic studies,  
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the average systolic BP was reduced the most when 
pharmacist case management was used [7-8]. Most 
hypertension studies with team management have been 
done in clinics or hospitals. Many communities, including 
rural settings, lack resources for a team approach within a 
clinic. However, teams of practitioners from different 
organizations could be formed within communities. For 
example, a physician from a medical clinic and a community 
pharmacist could collaborate to manage BP [9-10]. As 
community pharmacists expand their roles managing chronic 
conditions, opportunities will arise to promote provider-
community pharmacist collaboration to manage BP. 
 
Description of the Program 
The program to foster team-based management of blood 
pressure in the community was affiliated with the Iowa 
Department of Public Health’s (IDPH) Heart Disease and 
Stroke Prevention Program. The purpose of the program was 
to foster provider-pharmacist teams in small communities to 
use a team approach to manage high blood pressure. The 
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program was part of IDPH’s activities for the Million Hearts 
initiative. 
 
Objectives 
1) Conduct team building activities for provider-community 
pharmacist teams in small communities. 
2) Determine the impact of the team approach on 
practitioner-reported consequences. 
3) Identify obstacles to the team approach and ways to 
overcome them. 
 
Team Recruitment 
The goal was to recruit twelve medical clinic-community 
pharmacy pairs. Potential practice pairs were linked at the 
community level. Letters were sent to pharmacies and 
physicians for team recruitment. The pharmacies were on a 
list of 72 practice sites that provide practice experiences to 
University of Iowa pharmacy students, and provide advanced 
levels of pharmacy services. The initial physicians contacted 
were 33 members in the Iowa Research Network (IRENE), a 
practice-based research network in Iowa, and were working 
in micropolitan or rural areas.  
 
Practitioners who returned a fax were called to provide 
further information. Once a site stated its willingness to 
participate, it helped identify sites to form a provider-
pharmacist team. These prospective sites were contacted 
about participating using mailings, faxes, and telephone, 
depending on their preference. After a provider/clinic and a 
pharmacist/pharmacy were recruited for a team, a team 
building session was scheduled. 
 
Team Building 
Each team held a face-to-face 60-minute team building 
session, during which the project leaders facilitated a 
discussion to clarify team member views of team 
management of hypertension, identify specific roles for team 
members, discuss how to target patients, and develop 
communication procedures to exchange information. The 
teams completed and shared a worksheet describing their 
decisions for these topics. Some of the team building sessions 
included one provider and one pharmacist, while other 
sessions included multiple providers and/or pharmacists. 
 
A toolkit on team management of BP was used to support the 
provider-pharmacist teams. Both a printed version and an 
electronic version (e.g., PDF files) of the toolkit were given to 
the practitioners. Topics in the toolkit included: project leader 
contact information, description of the team model of BP 
management, evidence supporting the team approach, goals 
for the project, references to the current BP management 
guidelines (JNC7), detailed suggestions for management, 
sample interventions to address uncontrolled BP, and 
instructions for proper measurement of BP. In addition, 
numerous one-page patient education materials (e.g., diet 
and home BP monitoring) were included. 
 
Team Management 
Each provider-pharmacist team tailored the team 
management of BP model to fit their practices. For example, 
one team had the pharmacist fax summaries of BP visits, 
while another had the pharmacist call on the telephone. This 
tailoring began at the team building session, and continued 
throughout the team management process. The model for 
team management of BP contained the following activities: 
patient identification/recruitment, BP visits, and team 
member communication. 
 
Providers and pharmacists identified patients with newly 
diagnosed or uncontrolled hypertension. Some pharmacies 
ran a report, identifying patients with a BP medication 
prescribed by the participating provider(s), which was sent to 
the clinic to verify that provider(s) had seen them recently. 
Once confirmed, they had a registry of “shared BP patients,” 
which helped focus of team management of BP activities. 
Other teams simply had the provider and pharmacist identify 
patients at clinic or pharmacy visits respectively. 
 
Patients who participated in team management typically met 
with the pharmacist for a baseline assessment including BP 
measurement and discussion of anti-hypertensive 
medications. If the patient was not at goal, the pharmacist 
could ask about medication adherence and lifestyle issues. If 
it appeared the therapy was being taken as directed but not 
achieving the BP goal, the pharmacist would communicate 
with the provider or recommend the patient visit the 
provider. Some pharmacists recommended specific drug 
changes, while others relied solely on the provider to 
determine drug therapy adjustments. 
 
Pharmacists scheduled follow-up visits with patients as 
needed. The practitioners determined the need for follow-up 
visits for each patient during the team management period. 
The pharmacists logged the BP visits to track the extent of 
team management of BP and for the program evaluation. 
 
Purpose of Evaluation 
The purpose of this evaluation was to evaluate a program 
fostering physician-pharmacist teams in small communities 
for managing BP and identify obstacles to the team approach 
and ways to overcome them. The approach was to translate a 
proven physician-pharmacist team management within-clinic 
model to the community with team members working from 
different organizations. The program was conducted in both 
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rural towns and micropolitan areas in Iowa with several types 
of providers. 
 
Methods 
Given the time spent recruiting and conducting team building 
sessions, some teams had 5 months for the team 
management period, while others had 3 months. Providers 
and pharmacists were asked to complete two surveys about 
team management: one baseline and one follow-up. The 
surveys asked about team member relations, how the team 
BP management occurred, the presence of any obstacles, 
how the members communicated, suggested improvements, 
and their intention to continue team management of 
hypertension. The team relations were measured using the 
Physician-Pharmacist Collaboration Index (PPCI), assessing: 
Trustworthiness, Role Specification, and Relationship 
Initiation (1=strongly disagree – 7=strongly agree) [11-13]. A 
second data source was BP management logs maintained by 
the pharmacists including: number of patients receiving team 
management, number of visits (initial and follow-up), number 
of BP readings at goal, and pharmacist actions (e.g., patient 
education, communication with provider). Only de-identified 
data were collected in the pharmacy logs. 
 
The multi-case analyses began with combining team level 
information into a case report for each team. In addition to 
data about the team, the case report included a summary 
addressing three guide questions, which were used in case 
studies to help summarize the data [14]. Questions were: 1) 
How well did this team BP management work? 2) How was 
the BP management done for this team? and 3) What factors 
affected the success of this BP management team? In 
addition, the case reports were used in cross-case analyses 
based on overall case/team performance. 
 
Results 
Eleven provider-community pharmacist(s) teams participated 
throughout the state of Iowa (Table 1). Of these teams, six 
(54.5%) of the pharmacies were part of a chain, while eight 
(72.7%) of the clinics were part of a larger health system. The 
teams encompassed a total of twelve pharmacists of which 
eight (66.7%) were female, while seven (53.8%) of the 
thirteen providers were female. The pharmacists’ ages 
ranged from 26 to 64 with an average of 41.5, while the 
providers were slightly older ranging from 35 to 64 with an 
average of 48.6.  
 
Each team was rated on overall performance, based on two 
criteria: 1) extent to which they established a system to 
support the team management approach and 2) number of 
patients who participated in their team BP management. 
Initial judgments, made by a single judge, were assessed and 
discussed by other members to reach a single rating. Four 
teams were categorized as Worked-Well (Cases A, B, C, D), 
five teams as Limited-Success (E, F, G, H, I), and two teams as 
No-Team-Approach (J, K).  
 
The four Worked-Well teams were able to establish a system 
supporting the team management approach including: an 
effective process for identifying and recruiting patients, clear 
roles for team members, trusting relations between team 
members, and effective communication procedures. Having a 
system in place for the team management of BP, these four 
teams identified and recruited 6-18 patients who received 22-
33 BP visits (Table 2). Unlike some of the lesser performing 
teams, patient factors were not obstacles to their team 
management approach, and the practitioners committed 
time to team care.  
 
The five teams with Limited-Success either did not fully 
establish a system to support the team approach (Cases E, F, 
G) or they only recruited a few patients despite having a 
functional team system (Cases H, I). The teams without 
supportive systems did not have clear roles for team 
members, or lacked effective communication methods. Thus, 
when difficulties came up at their practices, such as 
identifying patients or patient decline of the team approach, 
they only provided minimal team management of BP.  
 
In contrast, two of the teams in this category appeared to 
have established functional systems to support their team 
management approach. However, few (<3 patients) received 
team management. Practitioner time (both provider and 
pharmacist) was a factor in both cases. In one case both team 
members had significant administrative responsibilities, 
which likely contributed to their time challenges.   
 
Two cases (Cases J, K) were rated as No-Team-Approach 
because team management of BP was not provided. These 
practitioners had problems with some or all of the system 
components. In addition, no patients were recruited, though 
some initial efforts were made to identify patients. The 
members did not report good/trusting relations during the 
project, lacking the rapport needed to build a team. In the 
absence of the team support system, some patient resistance 
came up, and the practitioners were not able to overcome it. 
It is possible that these teams did not receive a sufficient 
team building intervention. One case did not have a face-to-
face team building session with the project leaders due to 
miscommunication. Rather, the project leaders met 
separately with them and sent communications to each 
practitioner, which limited the focused discussions. While the 
pharmacist did conduct several patient visits, no coordination 
with the provider occurred.  
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The practitioners of the other case met face-to-face, but later 
reported confusion about their roles and a need for better 
communication (e.g., forms). Both roles and communication 
were covered during their team building session and their 
plans were recorded. It is unclear why this team did not 
develop, though both practitioners stated patients were not 
interested in the team approach. As a solo practitioner with a 
low patient volume, the provider may have preferred 
handling care herself. 
 
Discussion 
Overall, the project was partially effective in fostering 
provider-pharmacist team management of BP in smaller 
communities. The four successful teams established a system 
to support the team approach and actively provided team 
management of BP to the most patients. Five teams achieved 
limited success, either establishing a system for the team 
approach, but only recruiting a few patients, or establishing a 
low-functioning system for their team approach. Finally, two 
cases did not establish a team approach at all, by not 
developing a sufficient team support system.  
 
Objective 1 
Eleven provider-pharmacist teams were recruited, though not 
all effectively provided team management of high BP. The 
teams that did not establish a functioning system were the 
first three teams participating in team building. It is possible 
the project leaders learned to lead more effective team 
building sessions, though a consistent outline was followed 
for all sessions. While follow-up emails were sent after the 
team building, no further face-to-face communication was 
mandatory. Teams were encouraged to meet 6-8 weeks after 
the team building session to discuss the status of the team 
approach, and to identify improvements if needed. 
 
It is likely the team building program could be improved by 
providing more follow-up communication, which was 
intentionally limited to allow teams to operate on their own. 
Additional support could involve more communication after 
the initial team building session to help identify and resolve 
obstacles, to push progress in team care. Practitioners may 
not clearly recall their specific team roles, or might have 
problems with communications. Some follow-up team 
conference calls could boost members to more firmly 
establish a team system. Future work should incorporate 
team support such as conference calls or one-on-one 
interactions. 
 
Objective 2 
Objective 2 was to determine impact of the team approach 
on practitioner-reported consequences. Across the 11 cases, 
a total of 62 patients received BP visits with a pharmacist. 
This varied from a mean of 12.8 patients for the Worked-Well 
teams, 1.8 for the Limited-Success teams, and none for the 
No-Team-Care cases. In addition, the number of follow-up 
visits had a similar pattern, with averages of 13.8 for the 
Worked-Well teams, 5 for the Limited-Success and none for 
the No-Team-Care.  
 
Some of the teams, especially the lowest performing ones, 
mentioned patient issues as obstacles. Previous research on 
patient willingness to utilize new pharmacist services has 
shown that if the patient expects to receive a valuable 
service, then he/she is more willing to try it [15-16]. So, the 
manner in which the service was presented to the patients 
could have affected their interest. For example, if the 
pharmacist talked about better BP control or convenience for 
patients, they may have been more interested than if the 
pharmacist talked about how it would help the pharmacist or 
physician. How to approach patients was discussed during the 
team building sessions; however, specific talking points about 
team management were not provided. Future efforts should 
include some training and materials for practitioners, 
especially the pharmacists, to use when presenting the team 
care approach to patients. 
 
A second consequence assessed was the impact on provider-
pharmacist relations. The practitioner relations were 
generally good across the teams, though the lowest ratings 
occurred with the No-Team-Care cases. Trusting professional 
relations are a necessary, but not sufficient, characteristic for 
successful teams. These practitioners generally had little 
opportunity for face-to-face communication; however 
relationships developed when practitioners were committed 
to the plan established during the team building session. The 
communications from the BP visits helped demonstrate the 
pharmacists’ expertise, which has been identified as a 
determinant of trustworthiness [15-16].  
 
For most of these participants, this team approach was 
something new for both partners. It appears that in most 
cases, especially those less successful, members were 
conservative in expanding the pharmacists’ roles. Having the 
pharmacists conduct patient visits with a BP check was 
acceptable to most participants. However, fewer participants 
were comfortable with having the pharmacists recommend a 
change in drug therapy. It typically takes repeated 
communication for team members to fully develop their 
roles. For some of these teams, sporadic interactions 
between the providers and pharmacists limited their ability to 
develop a broader clinical role for the community 
pharmacists. Mechanisms for establishing new roles in teams 
such as these could be identified through future research. 
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Objective 3 
Objective 3 was to identify obstacles to the team approach 
and ways to overcome them. Several obstacles were 
identified during this project: failure to establish a team 
support system, relatively low levels of trust in provider-
pharmacist relations, broader system factors, practice 
workflow and time issues, and patient factors. Four cases did 
not establish a functional team system, suggesting a single 
team building session was insufficient for all teams. In 
addition to supplemental team building sessions, another 
idea is to have the team members complete action plans 
prior to the team building session to stimulate thinking about 
key issues such as identifying patients, practitioner roles, and 
communication processes. Such plans might better focus 
discussion and decision-making. Differences could be more 
readily identified and hopefully resolved, during the team 
building session. 
 
The teams entered this project with varying levels of 
interprofessional relations, but all were positive enough to 
agree to participate. For practitioners in separate 
organizations to collaborate under a team approach, a certain 
level of trust and open communication should be present. 
Some of the teams had previous relations to build on, while 
others did not. The challenge is to establish a working 
relationship built through strong performance contacting 
each other with useful information about patients (e.g., very 
high BP, uncontrolled for a long time, experiencing a likely 
adverse reaction). By showing their value, the team members 
can improve their relations and team approach.  
 
It is worth noting that the providers for two of the Worked-
Well teams were nurse practitioners. Given the small 
numbers involved, it is unclear whether nurse practitioners 
are more open to collaborating with community pharmacists 
than are physicians. Nurse practitioners may be socialized to 
be collaborative throughout their training, while physicians 
often are expected to “captain the ship”. Or, perhaps team 
process factors, such as communication between the 
practitioners could have affected the results [17]. Further 
research is needed to better investigate this result. 
 
The team members of four cases were located within the 
same building. Two of these were rated Worked-Well, while 
two were Limited-Success. Despite the potential for face-to-
face meetings, the two Limited-Success cases were unable to 
fully establish a functioning team system. Both had recently 
rented space for the community pharmacy within the clinic. It 
is likely the staffs of the clinic and pharmacy had insufficient 
history to establish open and flexible relationships. So, while 
the provider was open to using the team approach, the other 
clinic staff may have been less able to accommodate the 
team activities (e.g., communications). More work is needed 
to better determine which health systems will support a team 
model involving “outsiders”. 
 
Practitioners in some of the lower performing cases reported 
problems with performing team care activities. In today’s 
healthcare environment, workloads limit practitioners’ time 
with patients. This makes it more difficult to find time for BP 
visits, read and respond to communications, and conduct 
other team care activities. Some organizations build in 
redundancy, which can support flexibility for practitioners to 
allocate their time. Best practices could be shared with 
potential teams to consider as they discuss adopting a team 
approach to managing chronic conditions like hypertension. 
 
Some patient factors appeared as obstacles, such as an 
unwillingness to participate or confusion about their role 
under team care. Other problems with patient acceptance 
may be their perceived lack of a need for the team approach. 
Patients’ willingness to utilize a new pharmacy service has 
been related to the value they think they will receive from 
that service [18-19]. In addition, patients may not see BP 
management as an acceptable role for pharmacists, or might 
have privacy concerns in a community pharmacy. As 
mentioned previously, materials such as a script could be 
provided to engage patients to use a team approach in 
managing their BP. In addition, promotional materials could 
be provided, such as posters or brochures about the benefits 
of a team approach. For example, materials from the Team 
Up Pressure Down web site could be utilized [20]. Finally, a 
summary of this project has been incorporated into a report 
by ASTHO on Iowa’s Million Hearts Initiative [21]. 
 
The pharmacists were often reliant on the providers sending 
patients to them, limiting their role. By waiting to establish 
patients they limited their expansion of hypertension 
management. 
 
Conclusion 
This project showed that a team building program could 
support some practitioners in small communities to manage 
high blood pressure. While most of the teams had at least 
limited success, some changes could be made to improve the 
program: scheduled follow-up communications among the 
team members after the team building session, tools for 
communicating with patients, and guidance on adjusting 
practice sites to accommodate the team care activities. 
Future refinement of this team building project is 
encouraged. 
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Table 1: DESCRIPTION OF TEAMS AND COMMUNITIES 
 
TEAM 
Community 
Population (a) 
People >65 
years old 
(a) 
People 
Below 
Poverty (a) 
Prescriber 
Degree 
Prescriber 
Patients seen 
per Week 
Pharmacy 
Chain 
Prescriptions 
Dispensed per 
Week 
A 649 26.3% 4.8% PA 90 No 500 
B 5,688 20.1% 19.5% MD 120 Yes 1680 
C 1,958 18.8% 7.8% ARNP 110 Yes 725 
D 6,124 19.3% 15.1% MD 250 No 2000 
E 27,775 16.7% 15.4% MD 140 Yes 150 
F 13,608 3.5% 4.6% MD 75 No 1200 
G 27,775 16.7% 15.4% MD 105 Yes 100 
H 1,175 23.9% 4.8% MD 125 Yes 725 
I 1,066 31.4% 7.7% DO 70 No 1500 
J 6,807 14.0% 7.6% MD 50 Yes 1250 
K (b) 2,601 26.5% 3.9% - - Yes 500 
(a): Information is from Census data 2011 (Census.gov). 
(b): No survey returned from prescriber.  
 
 
 
Table 2: TEAM MANAGEMENT OF BLOOD PRESSURE 
 
 Team  
 Initial BP 
Visit (a) 
 Follow-Up BP 
Visit (a) 
Total BP 
Visits 
Percent of BP Visits 
at Goal Obstacles 
Worked-Well             
A 9 13 22 59.10% Time 
B 18 5 23 30.40% Lack of Patients, Interest 
C 6 27 33 39.40% - 
D 18 10 28 35.70% Lack of Patients and Time  
Limited-
Success             
E 1 2 3 35.70% 
Lack of Patients with 
uncontrolled HTN 
F  1 2 3 66.60% Communication 
G 3 4 7 57.10% - 
H 2 7 9 0% 
Lack of Patients with 
uncontrolled HTN 
I 2 10 12 25.00% Time to ID Patients 
No-Team 
Approach             
J  - - 0 N/A Lack of Patients and Time  
K (b) 2 0 2 0% - 
 
(a): Blood pressure visits were done with the pharmacist. 
(b): No survey returned from prescriber. 
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Appendix 1 Pharmacist Surveys 
Blood Pressure Team Management: Pharmacist Baseline Survey 
Q1.1 The purpose of this survey is to identify the factors that influence the development of collaborative working relationships 
between pharmacists and physicians. Please base your answers on the relationship with the physician with whom you work the 
most. Think, in general, about the interactions you have had with this physician over time.  Please indicate your level of agreement 
with each statement. 
        
1. I intend to keep working together with this physician. (1)               
2. In providing patient care, I need this physician as much as he/she needs me. (2)               
3. I trust this physician’s drug expertise. (3)               
4. I spend time trying to learn how I can help this physician provide better care (4)               
5. This physician works with me to overcome any disagreements that may emerge about my role 
in managing drug therapy. (5)               
6. Decision-making responsibilities for our patients’ drug therapy are shared between this 
physician and myself. (6)               
7. This physician depends on me as much as I depend on him/her. (7)               
8. Communication between this physician and me is two-way. (8)               
9. This physician is a credible practitioner. (9)               
10. I provide information to this physician about specific patients. (10)               
11. This physician and I negotiate to come to agreement on our activities in managing drug 
therapy. (11)               
12. In making decisions for our patients, both physician and pharmacist opinions are considered. 
(12)               
13. This physician and I are mutually dependent on each other in caring for patients. (13)               
14. My interactions with this physician are characterized by open communication by both 
parties. (14)               
15. I can count on this physician to do what he/she says. (15)               
16. There is cooperation between this physician and myself in managing the drug therapy of our 
patients. (16)               
17. I show an interest in helping this physician improve his/her practice. (17)               
18. Decision-making for our patients is coordinated between this physician and me. (18)               
 
Q1.2 In the past 6 months, please estimate the number of patients for whom you collaborated with this physician to manage 
hypertension: 
______ patients (1) 
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Your Demographic Information   
 
Age 
Q2.1   ______ years (1) 
Q2.2 Gender 
 Male (1) 
 Female (2) 
Q2.3 Please indicate your level of pharmacy training. (Check all that apply)    
 BS Pharmacy (1) 
 PharmD (2) 
 Residency (3) 
 Masters (4) 
 Other (Please list type and field of study or certification): (5) ____________________ 
Q2.4 Please check the one item that best describes your pharmacy:   
 Independent Community Pharmacy (3 or fewer stores under the same ownership) (1) 
 Small Chain Community Pharmacy (4-10 stores under the same ownership) (2) 
 Large Chain Community Pharmacy (more than 10 units under the same ownership) (3) 
 Mass Merchandiser (e.g., Wal-Mart) (4) 
 Supermarket Pharmacy (5) 
 Other (Please describe): (6) ____________________ 
Q2.5 On average, how many prescriptions does your pharmacy dispense per week? 
______ prescriptions/week (1) 
Q2.6 On average, how many prescriptions do you personally dispense per week? 
______ prescriptions/week: (1) 
Q2.7 About what percentage of patients at your pharmacy have hypertension? 
______ % patients with hypertension (1) 
Q end That's all! Please click the SUBMIT button to complete your survey. 
 
End Message: Your survey answers have been recorded. Good luck with your efforts toward team management of hypertension.  
Thank you for your participation in this project. 
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Blood Pressure Team Management Survey: Pharmacist Follow Up 
Q1.1 The purpose of this survey is to identify the factors that influence the development of collaborative working relationships 
between pharmacists and physicians. Please base your answers on the relationship with the physician with whom you work the 
most. Think, in general, about the interactions you have had with this physician over time.  Please indicate your level of agreement 
with each statement. 
        
1. I intend to keep working together with this physician. (1)               
2. In providing patient care, I need this physician as much as he/she needs me. (2)               
3. I trust this physician’s drug expertise. (3)               
4. I spend time trying to learn how I can help this physician provide better care. (4)               
5. This physician works with me to overcome any disagreements that may emerge 
about my role in managing drug therapy. (5)               
6. Decision-making responsibilities for our patients’ drug therapy are shared between 
this physician and myself. (6)               
7. This physician depends on me as much as I depend on him/her. (7)               
8. Communication between this physician and me is two-way. (8)               
9. This physician is a credible practitioner. (9)               
10. I provide information to this physician about specific patients. (10)               
11. This physician and I negotiate to come to agreement on our activities in managing 
drug therapy. (11)               
12. In making decisions for our patients, both physician and pharmacist opinions are 
considered. (12)               
13. This physician and I are mutually dependent on each other in caring for patients. 
(13)               
14. My interactions with this physician are characterized by open communication by 
both parties. (14)               
15. I can count on this physician to do what he/she says. (15)               
16. There is cooperation between this physician and myself in managing the drug 
therapy of our patients. (16)               
17. I show an interest in helping this physician improve his/her practice. (17)               
18. Decision-making for our patients is coordinated between this physician and me. 
(18)               
 
Q1.2 In the past 6 months, please estimate the number of patients for whom you collaborated with this physician to manage 
hypertension: 
______ patients (1) 
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Q2.1 Now that you have worked as part of a physician-pharmacist team to lower blood pressure, we would like to gather your 
impressions about the team management approach. Please answer the following questions.  How would you rate the 
performance/functioning of the team management approach to blood pressure over the last six months? 
 Poor (1) 
 Fair (2) 
 Good (3) 
 Very Good (4) 
 Excellent (5) 
Q2.2 Briefly describe how patients were identified for team care. Include both pharmacy and clinic. 
 
Briefly describe how the team management approach for blood pressure control affected the following 2 items: 
Q2.2.1 How the blood pressure visits to the pharmacy were scheduled and conducted. Include both initial and follow-up visits. 
Q2.2.2 How responsive the physician was to your requests and recommendations, e.g., timeliness, consideration/use of treatment 
recommendations and/or med changes. 
Q2.3 How did you communicate to the physician? Check all that apply. 
 Fax (1) 
 Email (2) 
 Phone (3) 
 Face to Face (4) 
Q2.4 How did the physician communicate to you? Check all that apply. 
 Fax (1) 
 Email (2) 
 Phone (3) 
 Face to Face (4) 
Q3.1 Did your team experience any difficulties while collaborating to improve blood pressure? 
 Yes (1) 
 No (2) 
Answer If Yes Is Selected 
Q3.2 Which of the following difficulties did your team experience while collaborating to improve blood pressure? Check all that 
apply. 
 Patients were unwilling to participate. (1) 
 There were few patients with uncontrolled hypertension. (2) 
 Lack of time. (3) 
 Poor communication. (4) 
 Other: Please type in any other difficulties that you experienced (5) ____________________ 
Answer If Count Q3.2 Is Greater Than or Equal to  1 
Q3.3 These were the difficulties you identified. Please check the box for those that were resolved. 
Answer If Count Q3.3 Is Greater Than or Equal to  1 
Q3.4 You have indicated that these items were resolved. 
Q3.5 Briefly describe how each item was resolved within the team. 
Q3.6 List or briefly describe any obstacles that currently exist to continuing team management of blood pressure. 
Q3.7 What were the benefits of the team management approach?  Check all that apply.  
 The approach helped patients control their blood pressure. (1) 
 The approach means more opportunity for pharmacists. (2) 
 This is a valuable platform we can continue to use for services. (3) 
 The physician/clinic's staff reported that the approach benefited physician time management. (4) 
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 The approach helped improve/increase communication between the pharmacist and physician. (5) 
 Other. (Please describe): (6) ____________________ 
 No benefits. (7) 
Q3.8 Please suggest improvements to the team management approach to managing blood pressure. (Feel free to comment on team 
training or actual team care in your community.) 
Q3.9 Do you intend to continue or expand the team management approach for managing blood pressure? 
 Yes (1) 
 No (2) 
Q3.10 That was the final question. You may go back and review your answers, or submit your survey at this time. Thank you.  
End Message:  Thank you for your participation in the team building initiative. We hope this was a positive experience and will 
lead to further physician-pharmacist collaboration in the future. 
 
 
  
http://z.umn.edu/INNOVATIONS                        2014, Vol. 5, No. 4, Article 180                        INNOVATIONS in pharmacy   12 
 
Case Study PHARMACY PRACTICE 
 
Appendix 2 Sample Case Reports 
Case A Worked Well 
This is a rural community located in northwestern Iowa. The population has 26.3% who are 65 years of age or older, 78.3% 
who have a high school degree or higher, and 4.8% who are below the poverty line. The per capita income is $19,228 (American 
towns.com). This community’s health care system consists of one medical clinic with a PA, one hospital within 25 miles, and one 
pharmacy.  
We enrolled one clinic that was affiliated with an integrated health system. In this clinic there is 1 provider (a physician 
assistant). The patient population consists of 15% Medicaid and 50% Medicare beneficiaries, wherein 50% of all clinic patients have 
hypertension. The provider team member was a male PA, age 50, who cares for about 90 patients per week.  
The pharmacy that paired with the clinic was an independent. The pharmacy staff includes 1 pharmacist and a clerk. The 
prescription volume averages 500 per week, all of which are dispensed by the team member. Of these prescriptions, 84% are for 
Medicaid beneficiaries and 15% are for Medicare beneficiaries. At this pharmacy 75% of the patients have hypertension. The 
pharmacist team member was a male, age 55, with a BS in pharmacy. 
Team relations from baseline to follow up changed somewhat during the team BP management period. The provider’s 
baseline rating for trustworthiness in the pharmacist was 7 and after the follow-up survey it ended at 7, while the pharmacist’s was 
6.33 and ended at 6.5.  The baseline rating for role specification of the provider was 6.44 and after the follow-up survey it ended at 
6.56, while the pharmacist’s was 4.11 and ended at 4.56. Baseline rating of relationship initiation for the provider was 6.33 and after 
the follow-up survey it ended at 6.33, while the pharmacist’s was 6 and ended at 7. Overall the team relations were improved.  
The Team planned the BP management as follows: Prescriber’s Roles: Refer patients to pharmacist as needed, Other clinic 
patients will also be referred to pharmacy, Clinic does offer BP checks; Pharmacist’s Roles: Conduct BP visits with patients, 
Communicate with provider as needed; Patient Identification: Pharmacist identified patients with hypertension who were willing to 
be monitored; Communication Strategies: Faxes sent to an electronic file and clinic staff reviews, STAT  fax-send BP’s of >160/90 to 
PA, Pharmacy will create BP check fax form with: patient, date, time and BP, Email addresses exchanged, Inform patient that 
collaboration is taking place; Patient Follow-up Schedule: PA re-checks patients in 1-2 weeks, then re-checks in 1 month then, if 
controlled every 3 months. 
 The total number of BP visits was 22 (9 initial, 13 F/U). The BP readings ranged from 128/58 to 156/90, with 13 of 22 
(59.1%) BP readings at goal. At 8 visits the pharmacist conducted patient education and at 1 visit made a recommendation to the 
prescriber to change therapy.  
 
Summary 
Guide Question 1: How well did this team BP management work? 
 This team had good relations at the start of this project, based on years of serving as the only provider and only pharmacist 
in the community. This was reflected in the relatively high relationship ratings at baseline and after the team management period. 
The pharmacist provided 22 BP visits, with 9 of these being initial visits. Four of the 9 (44.4%) initial BP readings were at goal, while 8 
of 13 (61.5%) of the follow-up BP readings were at goal. The pharmacist worked primarily with patients only (e.g., patient education) 
when BPs were not at goal. Overall, this BP management team worked well. 
 
Guide Question 2: How was the BP management done for this team? 
 The pharmacist identified patients with hypertension at the pharmacy and then asked about getting blood pressure 
checked. The provider made few referrals, since his clinic was able to readily conduct BP visits. The pharmacy provided the BP 
readings to the patients only, unless the readings exceeded 160/90 – which were sent to the physician assistant via STAT fax.  
 
Guide Question 3: What factors affected the success of this BP management team? 
 Team members knew each other professionally for years, which supported commitment to the team approach. The 
practitioners were able to trust each other, which allowed them to follow the team approach as they had planned.  
 A key challenge at this site was that there was only one pharmacist, so workload influenced ability to do BP checks. That is, 
when he was busy with dispensing activities, it was difficult to perform BP visits. Despite this, it appears that the pharmacy was able 
to establish a process for conducting the BP visits. Both team members reported that the team approach helped improve 
communication between them. Though little communication was recorded in the pharmacy’s BP log, none of the BPs were high 
enough to trigger the STAT fax process that had been established during the team building session.  
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 The provider stated a desire for an automated/easier way to enter the pharmacist-taken BP readings could be entered into 
the clinic’s electronic records. The pharmacist readings were faxed, but then had to be manually entered into the patient’s clinic 
record.  
 Patient acceptance of the team management approach was reported to be good. Some patients preferred to get their BP 
checked at the clinic, while others did not. 
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Case G Limited Success 
This is a micropolitan community in central Iowa. The population has 16.7% who are 65 years of age or older, 81.4% who 
have a high school diploma or higher, and 15.4% who are below the poverty line. The per capita income is $21,924 (Census.gov). This 
community’s health care system includes 11 medical clinics which have MDs, DOs, ARNPs and/or PAs, one hospital, and ten 
pharmacies.  
We enrolled one clinic that was affiliated with a larger organization. In this clinic there are 7 practitioners. The patient 
population consists of 8% Medicaid beneficiaries and 25% Medicare beneficiaries, wherein 20% of all clinic patients have 
hypertension. The physician team member was a male MD, age 52, who cares for about 150 patients per week. 
The pharmacy that paired with the clinic was a large chain, which owns 10 or more pharmacies in the state of Iowa. The 
pharmacy staff included 1 pharmacy technician and 1 pharmacist. The prescription volume averages 100 per week, all of which are 
dispensed by the team member. Of the prescriptions, 35% are for Medicaid beneficiaries and 50% are for Medicare beneficiaries. At 
this pharmacy 20% of the patients have hypertension. The pharmacist team member was a female, age 26, with a PharmD.  
Baseline rating for trustworthiness for the physician was 6.33 and after the follow-up survey it ended at 6.83 while the 
pharmacist’s was 5.33 and ended at 7.  The baseline rating for role specification of the physician was 4.67 and after the follow-up 
survey it ended at 5.56 and for the pharmacist’s was 4.89 and ended at 7. Baseline rating of relationship initiation for the physician 
was 4.67 and after the follow-up survey it ended at 6 while the pharmacist’s was 5.66 and ended at 7. Overall the team relations 
were improved.  
The Team planned the BP management as follows: Prescriber’s Roles: Refer patients to pharmacist as needed, OK to have 
pharmacist do BP checks, Uses Mediterranean food diet pyramid; Pharmacist’s Roles: Conduct BP visits with patients, Communicate 
with physician as needed, Give patients wallet car, Pharmacist will get Mediterranean diet from oldways.com; Patient Identification: 
Physician identifies patients with new HTN diagnosis; Communication Strategies: Faxes, Pharmacist can fax BP logs to prescriber, E-
prescribe comment section-uses to notify, Pharmacist can communicated with nurse, Add info to pharmacist notes in E-prescribing; 
Patient Follow-up Schedule: Doctor will see patient every 2 weeks if new med or dose change, Then in 3-6 months if at goal, 
depending on other issues 
The total number of BP visits was 7 (3 Initial and 4 Follow-up). The BP readings ranged from 110/79 to 128/97, with 4 of 7 at 
goal. At 7 visits the pharmacist conducted patient education, while at 1 visit the pharmacist made an adherence intervention. 
 
Summary 
Guide Question 1: How well did this team BP management work? 
 At baseline, both the pharmacist and physician rated each other about average in all three categories, but in the end both 
increased their ratings of the other in all three categories. The pharmacist provided 7 BP visits, with 3 of these being initial visits. For 
the initial BP readings, 2 of 3 were at goal, while 2 of 4 of the follow-up BP readings were at goal. During each BP visit the pharmacist 
would educate the patient on BP management as well as the uses of the Mediterranean diet. The pharmacist felt that the physician 
was very timely in following up with faxes and accepted all recommendations. Overall, this BP management team had limited 
success.  
 
Guide Question 2: How was the BP management done for this team? 
 The pharmacist looked up the patients seen by the physician and started the project with those 3 patients in mind. The 
physician also sent over other patients when they were interested, believing that it may be more comfortable for a patient to take 
their BP at another location besides their office. After each BP check the pharmacist would fax the information to the physician’s 
office and educate the patient on BP management as well as the uses of the Mediterranean diet.  
 
Guide Question 3: What factors affected the success of this BP management team? 
 The pharmacy was new and therefore had few patients, 3 of which were seen by this physician. So recruiting patients was 
challenging for this team. Though there were few patients and most had their BP controlled. The pharmacist felt that good 
communication was established with the physician. Both agree that more patients and more time for the project would be beneficial 
in the future. The pharmacist also felt that more disease management conditions could be added. 
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Case J No Team Approach 
This is a rural community located in central Iowa. The population has 14.0% who are 65 years of age or older, 89.5% who 
have a high school diploma or higher and 7.6% who are below the poverty line. The per capita income is $26,620 (Census.gov). This 
community’s health care system includes four medical clinics which have MDs, DOs, ARNPs and/or PAs, one hospital, and two 
pharmacies. 
We enrolled one clinic which was not affiliated with a larger organization. In this clinic there is 1 practitioner. The patient 
population consists of 0% Medicaid beneficiaries and 50% Medicare beneficiaries, wherein 50% of all clinic patients have 
hypertension. The physician team member was a female MD, age 47, who cares for about 50 patients per week in a solo practice. 
The pharmacy that paired with the clinic was a large chain, which owns over 10 pharmacies in the state of Iowa. The 
pharmacy staff includes 3 pharmacy technicians and 2 pharmacists. The prescription volume averages 1,250 per week, 500 of which 
are dispensed by the team member. Of the prescriptions, about 20% are for  Medicaid beneficiaries and 30% are for Medicare 
beneficiaries. At this pharmacy 40% of the patients have hypertension. Of the pharmacists, one is a female PharmD, age 26 and the 
pharmacist team member was a male PharmD, age 29. 
Baseline rating for trustworthiness for the physician was 5.83 and after the follow-up survey it ended at 6, while the 
pharmacist’s was 5.5 and ended at 6. The baseline rating for role specification of the physician was 2.67 and after the follow-up 
survey it ended at 3.11, while the pharmacist’s was 5.56 and ended at 5.56.  Baseline rating of relationship initiation for the 
physician was 3 and after the follow-up survey it ended at 4.33, while the pharmacist’s was 5.66 and ended at 6. Overall the team 
relations were somewhat improved from baseline to the end of the team management period.  
The Team planned the BP management as follows. Prescriber’s Roles: Refer patients to pharmacist as needed, Take BP 
before medication change, Call the pharmacy about medication costs; Pharmacist’s Roles: Conduct BP visits with patients, 
Communicate with physician as needed, Medication consultation, Provide medication costs to clinic when called; Patient 
Identification: Physician identifies patients with new HTN diagnosis, MD refers patients who need additional BP checks before 
making changes, Take BP at clinic and pharmacy before a medication change, Include patients who need more monitoring, 
Consultations between physician and pharmacist; Communication Strategies: Electronic prescription from MD to see a patient, Fax 
from Pharmacy, Electronic data exchange (EDI) - use to send note back to pharmacy, E-fax– also could do referral report; Patient 
Follow-up Schedule: follow-up for a new medication treatment in 2 weeks, wants patient to follow-up at clinic for refills. 
This efforts at team’s management of blood pressure resulted in no patients being cared for under the team approach. Both 
team members rated the performance of the team as poor. Though they did initial work to identify shared hypertension patients, 
subsequent work did not lead to collaboration for those patients. The provider stated that it was easier for her to manage the 
patient’s BP herself. Similarly, the pharmacist thought having more forms available and support to establish their system would have 
supported information exchange about BP levels among the team members. Further, both team members reported that patients 
were unwilling to participate in the team approach. Lack of time for the practitioner also was identified as an obstacle by both team 
members. Though the team approach was not adopted here, the practitioner relations and communication improved somewhat. 
Neither team member reported an interest in continuing team management, which is understandable given their lack of progress. 
 
Summary 
Guide Question 1: How well did this team BP management work? 
 This team’s relations at baseline were not rated very highly by the provider. Despite little progress on the actual team 
approach, the relations did improve somewhat. The team approach failed to be adopted at this site, with no patients being cared for 
under such an approach.  
 
Guide Question 2: How was the BP management done for this team? 
 This team discussed several ways to communicate about patients’ blood pressure, and at the team building session 
appeared to be willing to adopt the team approach. However, they were not able to establish a viable system for collaborating on 
their patient’s BP.    
 
Guide Question 3: What factors affected the success of this BP management team? 
 The team was not able to establish a system for routine communication of blood pressure readings. One part of this was 
that the pharmacist reported a desire for easy forms and a system to support the team approach. Similarly, the physician reported 
little need for adding a role for the pharmacist in managing patients’ BP. So, at a basic level, despite some initial progress (e.g., 
identifying shared patients with hypertension), this team was not able to develop some key components necessary for the team to 
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successfully function: a common vision with accepted roles and ways for adequate communication. Further, the provider rated 
relations with the pharmacist low.  
 Both team members reported that they were too busy to make changes in their practices that would support a team 
approach. This happened despite a positive team building session, and subsequent work to identify common patients. The 
physician’s office is a sole practitioner operation, which means resources were limited, which could have constrained flexibility to 
accommodate a team approach. The pharmacy was short a pharmacist for part of the team management period, which could have 
made it difficult to embrace changes to support the team approach.  
 Patient acceptance of the team management approach was reported to be low. Both team members reported that patient 
interest in a team approach was an obstacle. This physician reported caring for a relatively low number of patients weekly, which 
presumably allowed her to spend more time with each patient. Thus, it may be that she could have readily managed their BPs during 
clinic visits. Thus, patient may have seen little benefit from involving the pharmacist through a team approach. 
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